Enanta Pharmaceuticals Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Enanta pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Enanta Pharmaceuticals Company Profile Today - Breaking & Trending Today

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives $19.00 Consensus Price Target from Brokerages

Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have been assigned a consensus recommendation of “Hold” from the six brokerages that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the […] ....

Enanta Pharmaceuticals Stock Performance , Jpmorgan Chase Co , News Ratings For Enanta Pharmaceuticals Daily , Hermes Inc , Acadian Asset Management , Vanguard Group Inc , Analyst Recommendations For Enanta Pharmaceuticals , Enanta Pharmaceuticals Company Profile , Enanta Pharmaceuticals Inc , Enanta Pharmaceuticals , Get Free Report , Asset Management , Trexquant Investment , Get Free , Enanta Pharmaceuticals Daily ,

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Rating Upgraded by StockNews.com

Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Rating Upgraded by StockNews.com
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Clearstead Advisors , Enanta Pharmaceuticals , Enanta Pharmaceuticals Company Profile , Enanta Pharmaceuticals Stock Performance , Analyst Recommendations For Enanta Pharmaceuticals , Janney Montgomery Scott , News Ratings For Enanta Pharmaceuticals Daily , Jpmorgan Chase Co , Jump Financial , Institutional Trading Of Enanta Pharmaceuticals , Enanta Pharmaceuticals Inc , Free Report , Get Free Report , Enanta Pharmaceuticals Daily ,

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Forecasted to Post Q1 2025 Earnings of ($1.15) Per Share

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Forecasted to Post Q1 2025 Earnings of ($1.15) Per Share
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , News Ratings For Enanta Pharmaceuticals Daily , Enanta Pharmaceuticals Company Profile , Quest Partners , Jpmorgan Chase Co , Hermes Inc , Enanta Pharmaceuticals Inc , Board Of Administration Florida Retirement System , Enanta Pharmaceuticals , Enanta Pharmaceuticals Price Performance , Free Report , Enanta Pharmaceutical , Get Free Report , Florida Retirement System , Strs Ohio , Enanta Pharmaceuticals Daily ,

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Rating of "Hold" from Brokerages

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has been given an average recommendation of “Hold” by the six ratings firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have issued a buy recommendation on the […] ....

United States , Enanta Pharmaceuticals , Enanta Pharmaceuticals Stock Performance , News Ratings For Enanta Pharmaceuticals Daily , Enanta Pharmaceuticals Inc , Enanta Pharmaceuticals Company Profile , Jpmorgan Chase Co , Institutional Trading Of Enanta Pharmaceuticals , Analyst Recommendations For Enanta Pharmaceuticals , Yousif Capital Management , Tennessee Treasury Department , Get Free Report , Capital Management , Sigma Investments , Financial Advisors , Wisconsin Investment Board , Get Free , Enanta Pharmaceuticals Daily ,

Enanta Pharmaceuticals (NASDAQ:ENTA) Upgraded by StockNews.com to "Hold"

StockNews.com upgraded shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) from a sell rating to a hold rating in a research report sent to investors on Friday. Separately, JPMorgan Chase & Co. lowered their price target on Enanta Pharmaceuticals from $12.00 to $11.00 and set an underweight rating on the stock in a report on […] ....

Enanta Pharmaceuticals Inc , Nisa Investment Advisors , Institutional Investors Weigh In On Enanta Pharmaceuticals , News Ratings For Enanta Pharmaceuticals Daily , Tower Research Capital , Enanta Pharmaceuticals , Clearstead Advisors , Royal Bank , Analyst Recommendations For Enanta Pharmaceuticals , Enanta Pharmaceuticals Company Profile , Jpmorgan Chase Co , Us Bancorp , Enanta Pharmaceuticals Stock Performance , Free Report , Get Free Report , Investment Advisors , Research Capital , Enanta Pharmaceuticals Daily ,